Certified by Founder Lodge
Evozyne
United States - Chicago, IL
START UP
1 Disclosed Funding Rounds $81,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. B
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 28 ,2023 | Series B | $81,000,000 |
Valor Equity Partners
OrbiMed
Fidelity Investments
Paragon Biosciences
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Cascade AI | $3,750,000 | (Oct 25, 2024)
OLOID | $6,000,000 | (Oct 25, 2024)
Outrider | $62,000,000 | (Oct 25, 2024)
Attention | $14,000,000 | (Oct 25, 2024)
Aether Energy (YC W24) | $2,500,000 | (Oct 25, 2024)
